Drugmakers Warn Justices Oregon Pricing Law Risks Secrets

By Ivan Moreno · March 2, 2026, 2:28 PM EST

Pharmaceutical manufacturers have asked the U.S. Supreme Court to overturn Oregon's drug‑pricing transparency law, arguing it forces companies to publicly justify their pricing decisions and give up valuable trade secrets in...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Petition

Case Information

Case Title

Pharmaceutical Research and Manufacturers of America, Petitioner v. Sean O'Day, in His Official Capacity as Director of the Oregon Department of Consumer and Business Services

Case Number

Court

Supreme Court

Nature of Suit

Date Filed

February 24, 2026

Recent Articles By Ivan

February 13, 2026
CareDx Seeks High Court Review Of $45M False Ad Case
February 06, 2026
Insulet Gets $14.9M Fee Award For Trade Secret Trial Win
January 05, 2026
Fed. Circ. Examines Timing Of $452M Trade Secrets Suit
November 24, 2025
Justices Skip Appeal Challenging Denial Of Color TM
October 27, 2025
Judge Tosses Eli Lilly Suit Over Telehealth Weight Loss Drugs
October 06, 2025
Justices Skip TM Dispute Over Pink Color In Hip Implants
September 29, 2025
6 Copyright, TM Cases On Tap As Justices Begin New Term
July 01, 2025
$70M Verdict Boosts TriZetto's Trade Secrets Award To $370M
April 25, 2025
Insulet's $452M Trade Secrets Award Reduced To $59.4M
March 21, 2025
4th Circ. Revives TM Fight Over 'Westmont' Retirement Homes